Funded Grants

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neurostimulation therapy, recommended by Canadian guidelines as a first-line intervention for major depression that does not respond to an adequate course of pharmacological therapy, known as treatment-resistant depression (TRD).

Amyotrophic lateral sclerosis (ALS) is a nervous system disease that affects nerve cells (motor neurons) connecting muscle with the brain and spinal cord.

A common feature in almost all ALS cases is the build up of a protein called TDP-43 in the brain and spinal cord.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor function and ultimately death.

Males are twice as likely to develop ALS compared to females and the disease onset is also earlier in males than females.

Cells are constantly under stress due to several environmental and internal factors.

Amyotrophic Lateral Sclerosis (ALS) is a rare and fatal disease, which is characterized by degeneration of specific neurons called “Motor neurons” that control the movement of our muscles.

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the degeneration of motor neurons, typically resulting from gene mutations that facilitate abnormal protein aggregation.

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders in the world.

Regular cannabis use is indisputably linked to schizophrenia.